Gerald Dodd
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 15 | 2017 | 141 | 5.280 |
Why?
| Catheter Ablation | 28 | 2016 | 288 | 3.580 |
Why?
| Liver Neoplasms | 33 | 2012 | 506 | 2.210 |
Why?
| Liver | 29 | 2016 | 1637 | 2.100 |
Why?
| Portal Vein | 12 | 2016 | 76 | 2.010 |
Why?
| Tomography, X-Ray Computed | 51 | 2015 | 2285 | 1.760 |
Why?
| Carcinoma, Hepatocellular | 16 | 2005 | 211 | 1.280 |
Why?
| Diagnostic Imaging | 8 | 2017 | 275 | 1.270 |
Why?
| Liver Cirrhosis | 17 | 2003 | 227 | 1.150 |
Why?
| Blood Flow Velocity | 6 | 2016 | 387 | 1.090 |
Why?
| Microwaves | 6 | 2015 | 31 | 1.060 |
Why?
| Hepatectomy | 4 | 2016 | 119 | 1.040 |
Why?
| Liver Circulation | 7 | 2016 | 19 | 1.010 |
Why?
| Societies, Medical | 4 | 2013 | 663 | 1.000 |
Why?
| Models, Organizational | 3 | 2016 | 140 | 0.950 |
Why?
| Students, Medical | 2 | 2017 | 262 | 0.760 |
Why?
| Organizational Objectives | 3 | 2015 | 66 | 0.690 |
Why?
| Computer-Assisted Instruction | 2 | 2013 | 62 | 0.670 |
Why?
| Internship and Residency | 4 | 2013 | 926 | 0.630 |
Why?
| Delivery of Health Care | 2 | 2016 | 833 | 0.630 |
Why?
| Internet | 2 | 2013 | 596 | 0.620 |
Why?
| Radiology Information Systems | 1 | 2016 | 25 | 0.530 |
Why?
| Biotechnology | 1 | 2016 | 41 | 0.530 |
Why?
| Contrast Media | 12 | 2015 | 345 | 0.530 |
Why?
| Laboratories | 1 | 2017 | 95 | 0.520 |
Why?
| Fasciola hepatica | 1 | 2015 | 4 | 0.520 |
Why?
| Fascioliasis | 1 | 2015 | 6 | 0.510 |
Why?
| Organizational Innovation | 1 | 2016 | 132 | 0.500 |
Why?
| Cattle | 8 | 2016 | 921 | 0.490 |
Why?
| Personal Satisfaction | 1 | 2017 | 182 | 0.490 |
Why?
| Private Sector | 1 | 2015 | 51 | 0.480 |
Why?
| Prostate | 1 | 2015 | 156 | 0.470 |
Why?
| Curriculum | 3 | 2017 | 819 | 0.460 |
Why?
| Radiology Department, Hospital | 1 | 2014 | 15 | 0.460 |
Why?
| Health Care Reform | 1 | 2015 | 92 | 0.450 |
Why?
| Education, Medical | 2 | 2014 | 215 | 0.450 |
Why?
| Biological Science Disciplines | 1 | 2013 | 15 | 0.440 |
Why?
| Editorial Policies | 1 | 2014 | 45 | 0.440 |
Why?
| Education, Graduate | 1 | 2013 | 29 | 0.440 |
Why?
| Hepatic Veins | 4 | 2000 | 29 | 0.430 |
Why?
| Program Evaluation | 2 | 2017 | 822 | 0.430 |
Why?
| Schools, Medical | 1 | 2014 | 120 | 0.420 |
Why?
| Computers, Handheld | 1 | 2013 | 24 | 0.420 |
Why?
| Advisory Committees | 1 | 2014 | 208 | 0.420 |
Why?
| Publishing | 1 | 2014 | 124 | 0.420 |
Why?
| Hemangioma, Cavernous | 1 | 2012 | 14 | 0.410 |
Why?
| Periodicals as Topic | 1 | 2014 | 181 | 0.390 |
Why?
| International Cooperation | 1 | 2012 | 171 | 0.380 |
Why?
| Efficiency, Organizational | 2 | 2015 | 125 | 0.370 |
Why?
| Mobile Applications | 1 | 2013 | 141 | 0.370 |
Why?
| United States | 12 | 2016 | 12180 | 0.360 |
Why?
| Ultrasonography | 18 | 2013 | 633 | 0.360 |
Why?
| Thrombosis | 6 | 1997 | 298 | 0.360 |
Why?
| Societies, Scientific | 1 | 2010 | 47 | 0.350 |
Why?
| Research Support as Topic | 2 | 2010 | 108 | 0.350 |
Why?
| Ultrasonography, Interventional | 4 | 1999 | 123 | 0.350 |
Why?
| Magnetic Resonance Imaging | 14 | 2013 | 3044 | 0.350 |
Why?
| Education | 1 | 2010 | 95 | 0.340 |
Why?
| Cooperative Behavior | 1 | 2012 | 381 | 0.330 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2000 | 36 | 0.330 |
Why?
| Sensitivity and Specificity | 14 | 2016 | 1691 | 0.330 |
Why?
| Minimally Invasive Surgical Procedures | 2 | 2001 | 154 | 0.330 |
Why?
| Middle Aged | 52 | 2015 | 26733 | 0.320 |
Why?
| Colonic Neoplasms | 3 | 2004 | 215 | 0.310 |
Why?
| Diverticulitis, Colonic | 2 | 1999 | 7 | 0.310 |
Why?
| Cholelithiasis | 2 | 1999 | 31 | 0.300 |
Why?
| Humans | 93 | 2017 | 114655 | 0.300 |
Why?
| Research | 2 | 2010 | 394 | 0.300 |
Why?
| In Vitro Techniques | 5 | 2016 | 1016 | 0.290 |
Why?
| Cholangitis, Sclerosing | 2 | 1999 | 66 | 0.290 |
Why?
| Imaging, Three-Dimensional | 4 | 2016 | 511 | 0.280 |
Why?
| Hepatic Artery | 3 | 1996 | 49 | 0.280 |
Why?
| Terminology as Topic | 4 | 2014 | 187 | 0.270 |
Why?
| Lymph Nodes | 3 | 1997 | 419 | 0.270 |
Why?
| Cryosurgery | 2 | 2004 | 52 | 0.270 |
Why?
| Postoperative Complications | 7 | 2005 | 2128 | 0.270 |
Why?
| Liver Transplantation | 6 | 1996 | 707 | 0.270 |
Why?
| Neoplasms | 7 | 2014 | 2097 | 0.260 |
Why?
| Videoconferencing | 1 | 2006 | 57 | 0.260 |
Why?
| Lipoma | 3 | 1990 | 15 | 0.260 |
Why?
| Leiomyoma | 3 | 1990 | 44 | 0.250 |
Why?
| Aged | 35 | 2015 | 19069 | 0.250 |
Why?
| Female | 55 | 2017 | 59489 | 0.240 |
Why?
| Teaching | 1 | 2006 | 213 | 0.230 |
Why?
| Electrocoagulation | 2 | 2001 | 38 | 0.230 |
Why?
| History, 21st Century | 2 | 2016 | 159 | 0.220 |
Why?
| History, 20th Century | 2 | 2016 | 264 | 0.220 |
Why?
| Cholangiography | 2 | 2000 | 17 | 0.210 |
Why?
| Computer Simulation | 2 | 2010 | 872 | 0.210 |
Why?
| Perfusion | 3 | 2012 | 148 | 0.210 |
Why?
| Phantoms, Imaging | 2 | 2014 | 123 | 0.210 |
Why?
| Male | 52 | 2017 | 55580 | 0.200 |
Why?
| Forecasting | 2 | 2014 | 330 | 0.200 |
Why?
| Electric Injuries | 1 | 2001 | 1 | 0.200 |
Why?
| Animals | 14 | 2016 | 31698 | 0.190 |
Why?
| Head and Neck Neoplasms | 3 | 2011 | 427 | 0.190 |
Why?
| Adult | 35 | 2017 | 30543 | 0.190 |
Why?
| Information Dissemination | 2 | 2014 | 186 | 0.190 |
Why?
| Ultrasonography, Doppler, Duplex | 3 | 1995 | 39 | 0.180 |
Why?
| Carcinoma, Squamous Cell | 3 | 2011 | 577 | 0.180 |
Why?
| Cystadenocarcinoma, Papillary | 1 | 2000 | 5 | 0.180 |
Why?
| Kidney Transplantation | 5 | 1993 | 541 | 0.180 |
Why?
| Congresses as Topic | 2 | 2013 | 195 | 0.170 |
Why?
| Iopanoic Acid | 1 | 2000 | 1 | 0.170 |
Why?
| Radiography | 6 | 2012 | 812 | 0.170 |
Why?
| Ultrasonography, Doppler, Color | 2 | 2016 | 33 | 0.170 |
Why?
| Peritoneal Neoplasms | 1 | 2000 | 54 | 0.170 |
Why?
| Chemoembolization, Therapeutic | 1 | 2000 | 45 | 0.170 |
Why?
| Uterine Neoplasms | 2 | 1990 | 73 | 0.170 |
Why?
| Doxorubicin | 2 | 2011 | 285 | 0.170 |
Why?
| Equipment Design | 3 | 2016 | 508 | 0.160 |
Why?
| Liver Cirrhosis, Biliary | 1 | 1999 | 18 | 0.160 |
Why?
| Radiography, Interventional | 2 | 2014 | 104 | 0.160 |
Why?
| Image Processing, Computer-Assisted | 7 | 2008 | 683 | 0.150 |
Why?
| Radiography, Abdominal | 2 | 1999 | 32 | 0.150 |
Why?
| Arterial Occlusive Diseases | 2 | 1996 | 74 | 0.140 |
Why?
| Radiation Exposure | 1 | 2017 | 41 | 0.140 |
Why?
| Prospective Studies | 11 | 2005 | 6217 | 0.140 |
Why?
| Intergenerational Relations | 1 | 2017 | 15 | 0.140 |
Why?
| Ovarian Neoplasms | 3 | 1990 | 388 | 0.140 |
Why?
| Renal Artery Obstruction | 3 | 1995 | 29 | 0.140 |
Why?
| Hemangioma | 1 | 1997 | 41 | 0.140 |
Why?
| Inventions | 1 | 2016 | 18 | 0.130 |
Why?
| Infarction | 1 | 1996 | 12 | 0.130 |
Why?
| Models, Anatomic | 1 | 2016 | 87 | 0.130 |
Why?
| Equipment Failure Analysis | 1 | 2016 | 132 | 0.130 |
Why?
| Treatment Outcome | 6 | 2016 | 9088 | 0.130 |
Why?
| Biopsy, Needle | 5 | 1996 | 182 | 0.130 |
Why?
| alpha-Fetoproteins | 1 | 1996 | 31 | 0.130 |
Why?
| Organ Size | 1 | 2016 | 434 | 0.130 |
Why?
| Portasystemic Shunt, Surgical | 1 | 1995 | 4 | 0.120 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 1995 | 11 | 0.120 |
Why?
| Texas | 2 | 2013 | 188 | 0.120 |
Why?
| Ultrasonography, Doppler | 1 | 1995 | 105 | 0.120 |
Why?
| Awards and Prizes | 1 | 2016 | 56 | 0.120 |
Why?
| Program Development | 1 | 2017 | 341 | 0.120 |
Why?
| Research Design | 2 | 2014 | 928 | 0.120 |
Why?
| Constriction, Pathologic | 4 | 1996 | 208 | 0.120 |
Why?
| Education, Medical, Undergraduate | 1 | 2017 | 159 | 0.120 |
Why?
| Radiology, Interventional | 1 | 2014 | 26 | 0.120 |
Why?
| Reproducibility of Results | 4 | 2016 | 2762 | 0.120 |
Why?
| Ablation Techniques | 1 | 2014 | 29 | 0.120 |
Why?
| Time Factors | 10 | 2015 | 6115 | 0.110 |
Why?
| Bile Duct Diseases | 1 | 1994 | 15 | 0.110 |
Why?
| Neoplasm Invasiveness | 1 | 1995 | 442 | 0.110 |
Why?
| Radiopharmaceuticals | 2 | 2011 | 157 | 0.110 |
Why?
| Angiography | 3 | 2000 | 174 | 0.110 |
Why?
| Diagnosis, Differential | 7 | 2002 | 1342 | 0.110 |
Why?
| Dermoid Cyst | 2 | 1990 | 12 | 0.110 |
Why?
| Portography | 5 | 2000 | 11 | 0.110 |
Why?
| Esophageal Neoplasms | 1 | 1997 | 273 | 0.110 |
Why?
| Colorectal Neoplasms | 4 | 2009 | 615 | 0.110 |
Why?
| Cysts | 1 | 1994 | 93 | 0.110 |
Why?
| Bile Ducts, Intrahepatic | 3 | 2000 | 48 | 0.110 |
Why?
| Linear Models | 2 | 2013 | 768 | 0.110 |
Why?
| Radio Waves | 1 | 2013 | 16 | 0.110 |
Why?
| Information Services | 1 | 2013 | 44 | 0.100 |
Why?
| Social Networking | 1 | 2013 | 30 | 0.100 |
Why?
| Industry | 1 | 2013 | 65 | 0.100 |
Why?
| Thoracic Diseases | 1 | 1992 | 13 | 0.100 |
Why?
| Retrospective Studies | 15 | 2007 | 12545 | 0.100 |
Why?
| Planning Techniques | 1 | 2012 | 12 | 0.100 |
Why?
| Transplantation | 1 | 1992 | 23 | 0.100 |
Why?
| Lymphoproliferative Disorders | 1 | 1992 | 46 | 0.100 |
Why?
| Rhenium | 1 | 2011 | 4 | 0.100 |
Why?
| Radiation Protection | 1 | 2012 | 34 | 0.100 |
Why?
| Educational Measurement | 1 | 2013 | 243 | 0.100 |
Why?
| Data Collection | 1 | 2014 | 620 | 0.090 |
Why?
| Antibiotics, Antineoplastic | 1 | 2011 | 109 | 0.090 |
Why?
| Radiation Dosage | 1 | 2012 | 133 | 0.090 |
Why?
| Varicose Veins | 1 | 1991 | 14 | 0.090 |
Why?
| Neoplasm Staging | 2 | 1995 | 1167 | 0.090 |
Why?
| Alberta | 1 | 2010 | 10 | 0.090 |
Why?
| Vascular Diseases | 2 | 2004 | 230 | 0.090 |
Why?
| Orbit | 1 | 1991 | 59 | 0.090 |
Why?
| Education, Continuing | 1 | 2010 | 39 | 0.090 |
Why?
| Liposarcoma | 1 | 1990 | 26 | 0.090 |
Why?
| Documentation | 1 | 2012 | 167 | 0.090 |
Why?
| Therapy, Computer-Assisted | 1 | 2010 | 58 | 0.090 |
Why?
| Forensic Medicine | 1 | 1990 | 16 | 0.090 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2012 | 222 | 0.090 |
Why?
| Hospitals, Teaching | 1 | 2010 | 103 | 0.090 |
Why?
| Diaphragm | 2 | 2007 | 33 | 0.090 |
Why?
| Combined Modality Therapy | 3 | 2011 | 1121 | 0.090 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 76 | 0.080 |
Why?
| Leadership | 1 | 2013 | 292 | 0.080 |
Why?
| ROC Curve | 2 | 2005 | 442 | 0.080 |
Why?
| Physicians | 1 | 2017 | 772 | 0.080 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 1183 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 117 | 0.080 |
Why?
| Professional-Patient Relations | 1 | 2010 | 141 | 0.080 |
Why?
| Oxygen Radioisotopes | 1 | 2008 | 3 | 0.080 |
Why?
| Kidney | 3 | 1993 | 1188 | 0.080 |
Why?
| Patient Selection | 2 | 2004 | 641 | 0.080 |
Why?
| Sigmoid Diseases | 2 | 1999 | 10 | 0.080 |
Why?
| Mesentery | 2 | 1999 | 53 | 0.080 |
Why?
| Iopamidol | 4 | 1995 | 13 | 0.070 |
Why?
| Shoulder Pain | 1 | 2007 | 32 | 0.070 |
Why?
| Positron-Emission Tomography | 1 | 2008 | 259 | 0.070 |
Why?
| Wounds, Gunshot | 1 | 1990 | 190 | 0.070 |
Why?
| Computer Communication Networks | 1 | 2006 | 32 | 0.070 |
Why?
| Colorado | 2 | 2013 | 4099 | 0.070 |
Why?
| Rats, Nude | 3 | 2011 | 26 | 0.070 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 931 | 0.070 |
Why?
| Liver Diseases | 3 | 1996 | 255 | 0.060 |
Why?
| Chills | 1 | 2005 | 2 | 0.060 |
Why?
| Antineoplastic Agents | 2 | 2010 | 1879 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2015 | 1815 | 0.060 |
Why?
| Colon | 2 | 2004 | 233 | 0.060 |
Why?
| Aged, 80 and over | 6 | 2007 | 6345 | 0.060 |
Why?
| Syndrome | 1 | 2005 | 333 | 0.060 |
Why?
| Abdominal Neoplasms | 1 | 2004 | 26 | 0.060 |
Why?
| Fever | 1 | 2005 | 280 | 0.060 |
Why?
| Adolescent | 9 | 2004 | 17838 | 0.060 |
Why?
| Follow-Up Studies | 4 | 2005 | 4411 | 0.060 |
Why?
| Education, Medical, Graduate | 1 | 2007 | 368 | 0.060 |
Why?
| Laser Therapy | 2 | 2003 | 100 | 0.060 |
Why?
| Models, Biological | 1 | 2010 | 1620 | 0.050 |
Why?
| Predictive Value of Tests | 3 | 2000 | 1796 | 0.050 |
Why?
| Radiographic Image Enhancement | 2 | 2000 | 52 | 0.050 |
Why?
| Retroperitoneal Space | 2 | 1999 | 15 | 0.050 |
Why?
| Stents | 2 | 1997 | 475 | 0.050 |
Why?
| Cholecystostomy | 1 | 2001 | 4 | 0.050 |
Why?
| Cholecystitis | 1 | 2001 | 17 | 0.050 |
Why?
| Suction | 1 | 2001 | 31 | 0.050 |
Why?
| Multiple Trauma | 1 | 2001 | 96 | 0.050 |
Why?
| Feasibility Studies | 2 | 2003 | 740 | 0.050 |
Why?
| Pelvic Neoplasms | 1 | 2000 | 18 | 0.040 |
Why?
| Cholecystography | 1 | 2000 | 2 | 0.040 |
Why?
| Cystic Duct | 1 | 2000 | 4 | 0.040 |
Why?
| Hepatic Duct, Common | 1 | 2000 | 6 | 0.040 |
Why?
| Common Bile Duct | 1 | 2000 | 14 | 0.040 |
Why?
| Diathermy | 1 | 2000 | 2 | 0.040 |
Why?
| Models, Animal | 2 | 2012 | 344 | 0.040 |
Why?
| Cholecystectomy | 1 | 2000 | 45 | 0.040 |
Why?
| Liver Regeneration | 1 | 1999 | 29 | 0.040 |
Why?
| Stomach | 1 | 2000 | 102 | 0.040 |
Why?
| Laser Coagulation | 1 | 2000 | 54 | 0.040 |
Why?
| Omentum | 1 | 1999 | 8 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 114 | 0.040 |
Why?
| Algorithms | 3 | 2010 | 1467 | 0.040 |
Why?
| Embolization, Therapeutic | 1 | 2001 | 178 | 0.040 |
Why?
| False Negative Reactions | 1 | 1999 | 48 | 0.040 |
Why?
| Neoplasm Transplantation | 2 | 2010 | 228 | 0.040 |
Why?
| Image Enhancement | 1 | 2000 | 158 | 0.040 |
Why?
| Portal System | 2 | 1995 | 13 | 0.040 |
Why?
| Edema | 1 | 1999 | 119 | 0.040 |
Why?
| Perioperative Care | 1 | 1999 | 127 | 0.040 |
Why?
| Risk Assessment | 1 | 2007 | 2968 | 0.040 |
Why?
| Neoplastic Cells, Circulating | 2 | 1996 | 59 | 0.040 |
Why?
| Iothalamate Meglumine | 2 | 1996 | 4 | 0.040 |
Why?
| Analysis of Variance | 2 | 2011 | 1226 | 0.040 |
Why?
| Anesthesia | 1 | 1999 | 117 | 0.040 |
Why?
| Rats | 3 | 2011 | 4958 | 0.040 |
Why?
| Adenocarcinoma | 1 | 2004 | 795 | 0.040 |
Why?
| Administration, Oral | 1 | 2000 | 728 | 0.040 |
Why?
| Bile Ducts, Extrahepatic | 1 | 1997 | 24 | 0.040 |
Why?
| Ureteral Obstruction | 2 | 1994 | 54 | 0.030 |
Why?
| Intestines | 1 | 2000 | 326 | 0.030 |
Why?
| Appendix | 1 | 1997 | 27 | 0.030 |
Why?
| Punctures | 1 | 1996 | 36 | 0.030 |
Why?
| Kidney Diseases | 2 | 2004 | 350 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2001 | 858 | 0.030 |
Why?
| Ascites | 1 | 1996 | 32 | 0.030 |
Why?
| Colonic Polyps | 1 | 1997 | 67 | 0.030 |
Why?
| Drainage | 1 | 1996 | 151 | 0.030 |
Why?
| Regional Blood Flow | 2 | 2003 | 424 | 0.030 |
Why?
| Injections, Intravenous | 2 | 2010 | 198 | 0.030 |
Why?
| Pulsatile Flow | 1 | 1995 | 54 | 0.030 |
Why?
| Appendicitis | 1 | 1997 | 114 | 0.030 |
Why?
| Triiodobenzoic Acids | 3 | 2001 | 11 | 0.030 |
Why?
| Multivariate Analysis | 1 | 1999 | 1430 | 0.030 |
Why?
| Radionuclide Imaging | 2 | 2011 | 115 | 0.030 |
Why?
| Colic | 1 | 1994 | 6 | 0.030 |
Why?
| Vascular Patency | 1 | 1995 | 97 | 0.030 |
Why?
| Risk | 1 | 2017 | 812 | 0.030 |
Why?
| Peripheral Vascular Diseases | 1 | 1995 | 97 | 0.030 |
Why?
| Cholangiocarcinoma | 1 | 1994 | 38 | 0.030 |
Why?
| Gastrointestinal Hemorrhage | 1 | 1995 | 102 | 0.030 |
Why?
| Bile Duct Neoplasms | 1 | 1994 | 56 | 0.030 |
Why?
| Population Surveillance | 1 | 1997 | 392 | 0.030 |
Why?
| Systole | 1 | 1994 | 171 | 0.030 |
Why?
| Hyperthermia, Induced | 2 | 2005 | 65 | 0.030 |
Why?
| Vascular Resistance | 1 | 1994 | 337 | 0.030 |
Why?
| Pilot Projects | 1 | 2017 | 1373 | 0.030 |
Why?
| Recurrence | 1 | 1996 | 935 | 0.030 |
Why?
| Hemangioendothelioma | 1 | 1992 | 12 | 0.030 |
Why?
| Risk Factors | 4 | 2007 | 8631 | 0.030 |
Why?
| NADPH Dehydrogenase | 1 | 2012 | 8 | 0.030 |
Why?
| Nuclear Medicine | 1 | 2011 | 7 | 0.020 |
Why?
| Tromethamine | 1 | 2011 | 2 | 0.020 |
Why?
| Staining and Labeling | 1 | 2012 | 134 | 0.020 |
Why?
| Isotope Labeling | 1 | 2011 | 69 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2011 | 181 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 1993 | 321 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 316 | 0.020 |
Why?
| Acute Disease | 3 | 2001 | 910 | 0.020 |
Why?
| Random Allocation | 1 | 2011 | 335 | 0.020 |
Why?
| Finite Element Analysis | 1 | 2010 | 66 | 0.020 |
Why?
| Liposomes | 1 | 2011 | 146 | 0.020 |
Why?
| Chemotherapy, Adjuvant | 1 | 2011 | 332 | 0.020 |
Why?
| Infant | 2 | 1994 | 7959 | 0.020 |
Why?
| Technetium Tc 99m Pentetate | 1 | 2010 | 7 | 0.020 |
Why?
| Child, Preschool | 2 | 1994 | 9111 | 0.020 |
Why?
| Materials Testing | 1 | 2011 | 337 | 0.020 |
Why?
| Tissue Distribution | 1 | 2010 | 286 | 0.020 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 98 | 0.020 |
Why?
| Swine | 1 | 2011 | 700 | 0.020 |
Why?
| Health Status Disparities | 1 | 2009 | 200 | 0.020 |
Why?
| Efficiency | 1 | 2007 | 84 | 0.020 |
Why?
| Personnel Selection | 1 | 2007 | 62 | 0.020 |
Why?
| Glucose | 1 | 2011 | 896 | 0.020 |
Why?
| Heart Transplantation | 1 | 1992 | 665 | 0.020 |
Why?
| Hemorrhage | 2 | 2004 | 620 | 0.020 |
Why?
| Child | 3 | 1994 | 18407 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2017 | 4622 | 0.020 |
Why?
| Models, Statistical | 1 | 2008 | 599 | 0.010 |
Why?
| Lasers | 1 | 2005 | 121 | 0.010 |
Why?
| Prognosis | 1 | 1992 | 3327 | 0.010 |
Why?
| Medical Records | 1 | 2005 | 153 | 0.010 |
Why?
| Adrenal Gland Diseases | 1 | 2004 | 6 | 0.010 |
Why?
| Neoplasm Seeding | 1 | 2004 | 7 | 0.010 |
Why?
| Intestinal Obstruction | 1 | 2004 | 40 | 0.010 |
Why?
| Intestinal Perforation | 1 | 2004 | 39 | 0.010 |
Why?
| Hot Temperature | 1 | 2005 | 302 | 0.010 |
Why?
| Ultrasonic Therapy | 1 | 2003 | 10 | 0.010 |
Why?
| Cryotherapy | 1 | 2003 | 16 | 0.010 |
Why?
| Gallbladder | 1 | 2003 | 15 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2011 | 3531 | 0.010 |
Why?
| Incidence | 1 | 2007 | 2312 | 0.010 |
Why?
| Venous Pressure | 1 | 2000 | 8 | 0.010 |
Why?
| Burns | 1 | 2004 | 237 | 0.010 |
Why?
| Jejunum | 1 | 2000 | 24 | 0.010 |
Why?
| Postanesthesia Nursing | 1 | 1999 | 2 | 0.010 |
Why?
| Duodenum | 1 | 2000 | 62 | 0.010 |
Why?
| Ileum | 1 | 2000 | 90 | 0.010 |
Why?
| Equipment Failure | 1 | 2000 | 106 | 0.010 |
Why?
| Peritoneal Diseases | 1 | 1999 | 4 | 0.010 |
Why?
| Single-Blind Method | 1 | 2000 | 258 | 0.010 |
Why?
| Confidence Intervals | 1 | 2000 | 305 | 0.010 |
Why?
| Observer Variation | 1 | 2000 | 295 | 0.010 |
Why?
| Statistics as Topic | 1 | 2000 | 292 | 0.010 |
Why?
| Comorbidity | 1 | 2001 | 1448 | 0.010 |
Why?
| Abdomen | 1 | 1996 | 99 | 0.010 |
Why?
| Contraindications | 1 | 1996 | 85 | 0.010 |
Why?
| Hematocrit | 1 | 1996 | 87 | 0.010 |
Why?
| Heart Failure | 1 | 1988 | 1945 | 0.010 |
Why?
| Pelvis | 1 | 1996 | 90 | 0.010 |
Why?
| Needles | 1 | 1996 | 49 | 0.010 |
Why?
| Lymphatic Metastasis | 1 | 1996 | 275 | 0.010 |
Why?
| Hemodynamics | 1 | 2000 | 1012 | 0.010 |
Why?
| Reference Values | 1 | 1997 | 743 | 0.010 |
Why?
| Injections, Intra-Arterial | 1 | 1994 | 25 | 0.010 |
Why?
| Splenic Artery | 1 | 1994 | 13 | 0.010 |
Why?
| Mesenteric Artery, Superior | 1 | 1994 | 12 | 0.010 |
Why?
| Urography | 1 | 1994 | 13 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1995 | 167 | 0.010 |
Why?
| False Positive Reactions | 1 | 1995 | 109 | 0.010 |
Why?
| Pentetic Acid | 1 | 1993 | 12 | 0.010 |
Why?
| Hemoglobins | 1 | 1996 | 315 | 0.010 |
Why?
| Meglumine | 1 | 1993 | 13 | 0.010 |
Why?
| Osmolar Concentration | 1 | 1994 | 173 | 0.010 |
Why?
| Gadolinium DTPA | 1 | 1993 | 47 | 0.010 |
Why?
| Catheterization, Peripheral | 1 | 1994 | 101 | 0.010 |
Why?
| Gadolinium | 1 | 1993 | 73 | 0.010 |
Why?
| Blood Transfusion | 1 | 1996 | 293 | 0.010 |
Why?
| Adenoma, Bile Duct | 1 | 1992 | 1 | 0.010 |
Why?
| Drug Combinations | 1 | 1993 | 287 | 0.010 |
Why?
| Organometallic Compounds | 1 | 1993 | 98 | 0.010 |
Why?
| Hydronephrosis | 1 | 1992 | 28 | 0.010 |
Why?
| Graft Survival | 1 | 1993 | 446 | 0.010 |
Why?
| Case-Control Studies | 1 | 1996 | 3003 | 0.000 |
Why?
| Kidney Neoplasms | 1 | 1993 | 327 | 0.000 |
Why?
| Biopsy | 1 | 1992 | 1036 | 0.000 |
Why?
|
|
Dodd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|